LLY Oct 2023 350.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 02:20PM EDT
| Previous close | 0.0200 |
| Open | 0.0500 |
| Bid | 0.0000 |
| Ask | 0.0700 |
| Strike | 350.00 |
| Expiry date | 2023-10-20 |
| Day's range | 0.0500 - 0.0500 |
| Contract range | N/A |
| Volume | |
| Open interest | 186 |
BloombergObesity Drug Market Set to Hit $100 Billion by 2035, BMO Says
(Bloomberg) -- The global market for novel weight-loss drugs like Novo Nordisk A/S’s Ozempic and Wegovy is poised to reach $100 billion by 2035 as patients start to understand the efficacy of the medications.Most Read from BloombergWells Fargo Preps for Wealth Battle After $1 Billion TurnaroundChina’s Ultra-Rich Gen Zs Flock Home as Global Tensions RiseRaw Meat-Eating Liver King And Other Health Influencers Face Mounting LawsuitsAI Fantasy Fades as Wall Street Reels From Real-World Rate JumpUS t
Motley FoolAre Wall Street Analysts Wrong About Eli Lilly Stock?
Based on analysts' projections, you might think the pharmaceutical giant isn't worth investing in right now.
ZacksThe Zacks Analyst Blog Highlights Eli Lilly, Toyota Motor, Accenture, The Walt Disney and CVS Health
Eli Lilly, Toyota Motor, Accenture, The Walt Disney and CVS Health are part of the Zacks top Analyst Blog.
© 2023 Yahoo. All rights reserved.
